期刊文献+

三种血液净化方式治疗尿毒症并发症疗效对比 被引量:7

Therapeutic Effect Comparison among Three Dialysis for Uremia
下载PDF
导出
摘要 目的探讨血液灌流串联血液透析、血液透析滤过、普通血液透析治疗尿毒症在高血压、皮肤瘙痒、肾性贫血方面的疗效。方法将45例尿毒症行维持性血液透析(MHD)的患者随机分为血液灌流串联血液透析(HP+HD)组、血液透析滤过(HDF)组和常规血液透析(HD)治疗组。HP+HD组患者每周进行常规HD2次和1次HP+HD;HDF组患者每周常规HD2次和1次HDF;常规HD组每周3次常规HD,每次透析时间均为4h。其他治疗措施均相同。比较三组患者治疗前后平均血压、皮肤瘙痒程度评分、血红蛋白(Hb)和红细胞比容(Hct)的变化。结果HP+HD组和HDF组患者经过3个月的治疗较常规HD组患者血压下降、皮肤瘙痒程度减轻、血红蛋白及红细胞比容升高,差异均有显著性(P<0.05);HP+HD组与HDF组比较差异也有显著性(P<0.05)。结论尿毒症患者在常规HD治疗的同时定期接受HP或HDF治疗,可改善维持性透析患者顽固性高血压、皮肤瘙痒、贫血,提高患者生存质量。尤以HP+HD更为有效。 Objective To compare the effect among combined hemodialysis-hemoperfusion,hemodiafiltration and conventional hemodialysisn on hypertension, skin pruritus, anemia in maintenance hemodialysis patients, to find an effective treatment method. Methods 45 maintenance hemodialysis patients were divided randomly into three groups,respectively treated with combined hemodialysis-hemoperfusion, hemodiafiltration and conventional hemodialysis. Observe the change of blood pressure, score of skin pruritus, the level of hemoglobin and hematocrit value between pretherapy and post-treatment. Results After three months' treatment, blood pressure,score of skin pruritus are downer in groups of HP+HD,HDF than HD (P〈0.05), the level of hemoglobin and hematocrit value are higher in groups of HP+HD,HDF than HD (P〈0.05). Among three groups HP+HD is the best. Conclusion Maintenance hemodialysis patients received regular hemodialysis added with liP, HDF can effectively clean middle molecule toxins, then hypertension,skin pruritus, anemia in patients are improved. HP is especially useful.
出处 《中国现代医生》 2008年第32期30-31,34,共3页 China Modern Doctor
关键词 血液灌流 血液透析滤过 血液透析 尿毒症 疗效 Hemoperfusion Hemodiafitration Conventional hemodialysisn Uremia Therapeutic effect
  • 相关文献

参考文献11

  • 1[1]Rasic S,Kulenovic I,Haracic A,et al.Left ventriculsr hypertrophy and risk factor for its development in uraemic patients[J].Bosn J Basic Med Sci,2004,4(1):34-40.
  • 2[2]Szepietowski JC,Salomon J.Uremic pruritus:still an important clinical problem[J].J Am Acad Dermatol,2004,51(5):842-843.
  • 3[3]Lindenteld J.Prevalence of aneima and the effects on mortality in patients with heart failure[J].Am Heart J,2005,149(3):391-401.
  • 4[4]Grekas D,Bamichas G,Bacharaki D.Hypertension in chronic hemodialysis patients:current view on pathophysiology and treatment[J].Clin Nephrol,2000,53(3):164-168.
  • 5严玉澄,林爱武,钱家麒.血液透析症状性低血压和难治性高血压患者相对血容量变化的比较[J].中华肾脏病杂志,2005,21(7):417-420. 被引量:22
  • 6李洪,黄烈诚.尿毒症毒素研究进展与血液吸附的再应用[J].中国血液净化,2004,3(8):454-458. 被引量:49
  • 7段晓峰,王开颜,刘惠兰.尿毒症患者瘙痒的发病机制及治疗研究进展[J].中国血液净化,2003,2(12):669-672. 被引量:151
  • 8[8]Wang JY,Hotta T,Murate T,et al.Growth inhibition of erythroid colonies by antolongons sera and the clinical effect of orythropoirtin in chronic renal disease[J].Rinsho Ket sueki,1989,30(7):975-979.
  • 9[9]Boenisch O,Ehmke KD,Heddergott A,et al.C-reactive protein and cytokine plasma levels in hemodialysis patients[J].J Am Soc Nephrol,2002,15(5):547-551.
  • 10林善琰.当代肾脏病学[M].上海:上海科技教育出版社,2001.814-819.

二级参考文献38

  • 1严玉澄,林爱武,钱家麒.相对血容量的测定对预测血液透析低血压患者低血压发生的价值[J].上海医学,2004,27(8):548-551. 被引量:1
  • 2杨国亮 王侠生.现代皮肤病学[M].上海:上海医科大学出版社,1998.504.
  • 3[1]Mikhalovsky SV. emerging technologies in extracorporeal treatment:focus on adsorption. Perfusion, 2003,18(7) :47 - 54
  • 4[2]Vanholder R. Review on uremic toxins: Classification, concentration,and interindividual variability. Kidney International,2003,63(5): 1934- 1943
  • 5[3]James F. Removal of Middle Molecules with Sorbents. Artif Cells Blood Substit Immobil Biotechnol, 2002,30(5- 6):547- 554
  • 6[4]Clark WR. Middle molecules and small- molecular- weight protiens in ESRD: Properties and strategies for their removal. Adv Ren Replace Ther,2003, 10(4) :270 - 278
  • 7[5]Morena MD. Effect of novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int,2003,63(3):1150-4
  • 8[6]Winchester JF. The next step from high - flux dialysis: application of sorbent technology. Blood Purif, 2002,20(1):81-6
  • 9[7]Vanholder R. Survival of hemodialysis patients uremic toxin removal.Artifi Organ,2003,27 (7) :218 - 23
  • 10[9]Schlaeper C. High clearance continuious renal replacement therapy with a modified dialysis machine. Kidney Int Suppl, 1999,72(56): S20 - 3

共引文献233

同被引文献15

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部